Can SARS-CoV-2 Infection Accelerate the Onset of an Autoimmune Disease?
Researchers evaluated the possibility of SARS-CoV-2 infection accelerating the onset of an autoimmune rheumatic disease.
Researchers evaluated the possibility of SARS-CoV-2 infection accelerating the onset of an autoimmune rheumatic disease.
Most patients report not having participated in a lupus clinical trial, despite interest.
Despite the benefits of using immunoassays in clinical laboratories, various types of interference can lead to inaccurate results that cloud clinical decision-making.
Maternal diet may be correlated with certain autoimmune-associated diseases in offspring.
A number of therapeutic options exist for patients with psoriasis, including phototherapy and systemic and biologic agents.
An incidental finding in an asymptomatic woman is followed by rapid deterioration of her condition.
Immunosuppressive agents do not increase the risk of HCV flares in anti-HCV-positive lupus patients.
The higher the exposure to mercury, the higher the level of autoantibodies, found the researchers.
Topical corticosteroids and ultraviolet therapies are still proving to be strong competitors in psoriasis treatment.
Patients with certain autoimmune diseases have a higher risk for varicella zoster infection, but the rates were not significant among patients with psoriasis.